There is growing evidence that activated synovial fibroblasts, as part of a
complex cellular network, play an important role in the pathogenesis of rh
eumatoid arthritis. In recent years, significant progress has been made in
elucidating the specific features of these fibroblasts. It has been underst
ood that although macrophage and lymphocyte secreted factors contribute to
their activation, rheumatoid arthritis synovial fibroblasts (RA-SFs) do not
merely respond to stimulation by pro-inflammatory cytokines, but show a co
mplex pattern of molecular changes also maintained in the absence of extern
al stimulation. This pattern of activation is characterized by alterations
in the expression of regulatory genes and signaling cascades, as well as ch
anges in pathways leading to apoptosis. These together result in the upregu
lation of adhesion molecules that mediate the attachment of RA-SFs to the e
xtracellular matrix and in the overexpression of matrix degrading enzymes t
hat mediate the progressive destruction of the joints. In addition, activat
ed RA-SFs exert specific effects on other cell types such as macrophages an
d lymphocytes. While the initiating step in the activation of RA-SFs remain
s elusive, several key pathways of RA-SF activation have been identified. H
owever, there is so far no single, specific marker for this phenotype of RA
-SF. It appears that activated RA-SFs are characterized by a set of specifi
c properties which together lead to their aggressive behavior.